BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murakami Y, Fukuda H, Muromoto R, Hirashima K, Ishimura K, Fujiwara K, Ishihara J, Matsuda T, Watanabe M, Shuto S. Design and Synthesis of Benzene Congeners of Resolvin E2, a Proresolving Lipid Mediator, as Its Stable Equivalents. ACS Med Chem Lett 2020;11:479-84. [PMID: 32292553 DOI: 10.1021/acsmedchemlett.9b00596] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Arai S, Fujiwara K, Kojima M, Aoki-Saito H, Yatomi M, Saito T, Koga Y, Fukuda H, Watanabe M, Matsunaga S, Hisada T, Shuto S. Design and Synthesis of Cyclopropane Congeners of Resolvin E3, an Endogenous Pro-Resolving Lipid Mediator, as Its Stable Equivalents. J Org Chem 2022. [PMID: 35866588 DOI: 10.1021/acs.joc.2c01110] [Reference Citation Analysis]
2 Small M, Serhan CN, Libreros S, Nshimiyimana R. E-series Resolvin Metabolome, Biosynthesis and Critical Role of Stereochemistry of Specialized Pro-Resolving Mediators (SPMs) in Inflammation-Resolution: Preparing SPMs for Long COVID-19, Human Clinical Trials, and Targeted Precision Nutrition. Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Deyama S, Minami M, Kaneda K. Resolvins as potential candidates for the treatment of major depressive disorder. J Pharmacol Sci 2021;147:33-9. [PMID: 34294370 DOI: 10.1016/j.jphs.2021.05.002] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther 2021;:107879. [PMID: 33915177 DOI: 10.1016/j.pharmthera.2021.107879] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 42.0] [Reference Citation Analysis]
5 Reinertsen AF, Primdahl KG, Shay AE, Serhan CN, Hansen TV, Aursnes M. Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4. J Org Chem 2021;86:3535-45. [PMID: 33534565 DOI: 10.1021/acs.joc.0c02913] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Ishimura K, Fukuda H, Fujiwara K, Muromoto R, Hirashima K, Murakami Y, Watanabe M, Ishihara J, Matsuda T, Shuto S. Synthesis of Resolvin E1 and Its Conformationally Restricted Cyclopropane Congeners with Potent Anti-Inflammatory Effect. ACS Med Chem Lett 2021;12:256-61. [PMID: 33603972 DOI: 10.1021/acsmedchemlett.0c00639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Libreros S, Shay AE, Nshimiyimana R, Fichtner D, Martin MJ, Wourms N, Serhan CN. A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution. Front Immunol 2020;11:631319. [PMID: 33643307 DOI: 10.3389/fimmu.2020.631319] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
8 Guimarães RC, Gonçalves TT, Leiria LO. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. Br J Pharmacol 2021;178:531-49. [PMID: 33169375 DOI: 10.1111/bph.15321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang M, Sayyad AA, Dhesi A, Orellana A. Enantioselective Synthesis of 7(S)-Hydroxydocosahexaenoic Acid, a Possible Endogenous Ligand for PPARα. J Org Chem 2020;85:13621-9. [PMID: 32954732 DOI: 10.1021/acs.joc.0c01770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chiang N, Serhan CN. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 2020;64:443-62. [PMID: 32885825 DOI: 10.1042/EBC20200018] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 56.5] [Reference Citation Analysis]